https://www.taxtmi.com/news?id=70794 Fermenta Biotech reports higher consolidated revenue and EBITDA for 9MFY26 driven by Vitamin D3 growth, presents figures with and without real estate value unlocking, and discloses a Board approved transfer of the Environment Division to a wholly owned subsidiary on a slump sale basis. The company records a one time labour code related employee benefits expense, a non recurring insurance claim in other income, and Board approval of INR 110 crore capex for plant based Vitamin D3 and enzyme capacity expansion. en-us Tue, 10 Feb 2026 17:01:05 +0530 Tue, 10 Feb 2026 17:01:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=70794 Fermenta Biotech reports higher consolidated revenue and EBITDA for 9MFY26 driven by Vitamin D3 growth, presents figures with and without real estate value unlocking, and discloses a Board approved transfer of the Environment Division to a wholly owned subsidiary on a slump sale basis. The company records a one time labour code related employee benefits expense, a non recurring insurance claim in other income, and Board approval of INR 110 crore capex for plant based Vitamin D3 and enzyme capacity expansion. News - Tue, 10 Feb 2026 17:01:05 +0530 https://www.taxtmi.com/news?id=70794